Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Pro-Dex, Inc. - Common Stock (NQ:PDEX)

36.24 +5.61 (+18.32%)
Streaming Delayed Price Updated: 4:00 PM EDT, Oct 31, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 137,010
Open 32.45
Bid (Size) 31.26 (2)
Ask (Size) 36.25 (2)
Prev. Close 30.63
Today's Range 32.03 - 36.33
52wk Range 23.47 - 70.26
Shares Outstanding 3,262,004
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
PRO-DEX INC (NASDAQ:PDEX) Tops Q1 FY2026 Earnings and Revenue Estimates
Pro-Dex (PDEX) Q1 FY2026 earnings crush estimates, with revenue and EPS beating forecasts. Stock surges on strong results and a major investment gain. 
Via Chartmill
Pro-Dex, Inc. Announces Fiscal 2026 First Quarter Results
Via ACCESS Newswire

Performance

YTD
-21.8%
-21.8%
1 Month
+7.3%
+7.3%
3 Month
-23.5%
-23.5%
6 Month
-21.0%
-21.0%
1 Year
+16.8%
+16.8%

More News

Read More
Pro-Dex, Inc. Announces Clarification Related to Trading Symbol
Via ACCESS Newswire
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
Is PRO-DEX INC (NASDAQ:PDEX) suited for growth investing?
Via Chartmill
PRO-DEX INC (NASDAQ:PDEX) is a candidate for growth investors. Here's why.
Via Chartmill
Pro-Dex, Inc. Announces Fiscal 2024 Fourth Quarter and Full-Year Results
Via ACCESSWIRE
12 Health Care Stocks Moving In Tuesday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
Pro-Dex Revenue Jumps 16% in Fiscal Q4
Via The Motley Fool
Pro-Dex, Inc. Announces Fiscal 2025 Fourth Quarter and Full-Year Results
Via ACCESS Newswire
PTC Therapeutics To Rally Around 61%? Here Are 10 Top Analyst Forecasts For Tuesday
Via Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
Pro-Dex, Inc. Announces Fiscal 2025 Third Quarter and Nine-Month Results
Via ACCESS Newswire
Pro-Dex Inc (NASDAQ:PDEX): A Strong Candidate for Little Book Investors
Via Chartmill
Evaluating PRO-DEX INC (NASDAQ:PDEX) for Growth Investment Opportunities.
Via Chartmill
Is PRO-DEX INC (NASDAQ:PDEX) suited for growth investing?
Via Chartmill
Pro-Dex, Inc. Announces Fiscal 2025 Second Quarter and Six-Month Results
Via ACCESS Newswire
Lantheus Stock Doubled In A Year Amid Wide Use Of Its AI-Enabled Medical Devices
Via Investor's Business Daily
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
Via Benzinga
PRO-DEX, INC. Announces Fiscal 2025 First Quarter Results
Via ACCESSWIRE
Starbucks To Rally Around 21%? Here Are 10 Top Analyst Forecasts For Monday
Via Benzinga
PDEX Stock Earnings: Pro-Dex Misses EPS, Beats Revenue for Q3 2024
Via InvestorPlace

Frequently Asked Questions

Is Pro-Dex, Inc. - Common Stock publicly traded?
Yes, Pro-Dex, Inc. - Common Stock is publicly traded.
What exchange does Pro-Dex, Inc. - Common Stock trade on?
Pro-Dex, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Pro-Dex, Inc. - Common Stock?
The ticker symbol for Pro-Dex, Inc. - Common Stock is PDEX on the Nasdaq Stock Market
What is the current price of Pro-Dex, Inc. - Common Stock?
The current price of Pro-Dex, Inc. - Common Stock is 36.24
When was Pro-Dex, Inc. - Common Stock last traded?
The last trade of Pro-Dex, Inc. - Common Stock was at 10/31/25 04:00 PM ET
What is the market capitalization of Pro-Dex, Inc. - Common Stock?
The market capitalization of Pro-Dex, Inc. - Common Stock is 118.22M
How many shares of Pro-Dex, Inc. - Common Stock are outstanding?
Pro-Dex, Inc. - Common Stock has 118M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.